EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

Acute stress may impair key brain functions involved in managing emotions — particularly in...

Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...

Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after...

Content from other channels on our network

Coles awards $3.5m to support Aussie producers

FoodTech Qld sets new sustainable packaging standards

GNT shows how plant-based colours can liven up snacks

Getting a handle on a shrink bag for turkey

Six on the shelf: from frozen snacks to GF treats

Victorian home demonstrates grid resilience solution

Australian-made green metals get $19.8m investment

Why grid orchestration must be Australia's next energy imperative

Recycled water to keep Victorian sporting grounds green

Productivity Summit announcement welcomed

Medicare chronic wound care scheme set to benefit 20,000/year

Urinary incontinence and cardiovascular disease risk in women

Pharmacist distraction during dispensing — extent and sources

Ambulance ramping — its "very real potential human consequences"

Could this game wave goodbye to nerve pain?